March 3, 2021
Intensity’s team continues its growth trajectory in 2021 with the addition of Dr. Richard Manning. Dr. Manning brings over 25 years of expertise in biopharmaceutical and life science industries to the firm.
Intensity joined Secretariat on February 1, 2023.
Intensity, LLC, an economic consulting firm generating influential research and in-depth analysis, announced today the key hire of Managing Director Dr. Richard Manning, based in Washington, D.C.
Dr. Manning will work closely with key leadership members to augment Intensity’s strong credentials serving high-stakes litigation in the biopharmaceutical and life science industries. Dr. Manning’s experience includes testifying in U.S. District Court, the Delaware Court of Chancery, and the International Chamber of Commerce. He has served as a consulting expert and prepared reports on various matters in the biopharmaceutical and healthcare industries. His career includes 14 years as an executive at multinational pharmaceutical companies, where he led economic analysis and strategy development to shape practices related to emerging business-environment concerns.
“I am pleased to be part of such a unique team,” Dr. Manning said, “Intensity has outstanding economists, analysts with strong technical skills, and few – maybe more than a few! – fellow University of Chicago Ph.Ds. This is precisely where I want to be, and I am very much looking forward to what we will be able to accomplish together.”
Patrick Sanders, CEO of Intensity, is delighted to welcome Dr. Manning as the role aligns with his vision of providing additional subject-matter experts to the growing team while preserving exceptional service and outstanding work product values.
“Richard’s depth of knowledge in bioscience and pharma, and his impeccable reputation, is a fabulous addition to our team. We are thrilled for the expertise that he will provide to our clients – he offers the full package as an analyst, economist, researcher, and academic.”
Prior to joining Intensity, Dr. Manning was a partner with Bates White, an economic consulting firm offering analysis and expert testimony services to law firms, Fortune 500 companies, and government agencies. Previously, Dr. Manning was executive director at Merck & Co., Inc., and he was senior director at Pfizer, Inc. Also, he was a director in the Advisory Strategy Group at PricewaterhouseCoopers. And as an academic, Dr. Manning was a member of the economics department at Brigham Young University and a visiting faculty at the University of Chicago Graduate School of Business.
He holds a Bachelor of Arts degree in Economics from Brigham Young University. He received his Master of Arts and Doctor of Philosophy in Economics from the University of Chicago.
Seven Strategies for Resolving Family-Owned Business Disputes in the Middle East
Family businesses have long been the backbone of the Middle East’s economy, contributing significantly to the region’s prosperity. They are built on a foundation of shared values, traditions, and a deep sense of commitment to the company and its success.
Chris Robinson provided an expert report and trial testimony on behalf of Miraca Life Sciences, Inc. in wrongful termination litigation. The jury awarded less than $1 million, an amount determined from Mr. Robinson’s testimony.
AI Reckoning and Sustainability Challenges Drive Consultants’ Predictions for 2025
As we step into 2025, the fight against fraud in the UK is evolving, with a spotlight on whistle-blower incentivization. Director Ben Boorer highlights critical developments in the UK’s corporate compliance landscape in an article for Consultancy UK.